Sutro Biopharma has dosed the first patient in its Phase 1 clinical trial of STRO-006, a next-generation antibody-drug conjugate targeting integrin β6 (ITGB6) in advanced solid tumors. This trial will assess safety, pharmacokinetics, and preliminary anti-tumor activity in various ITGB6-expressing cancers, including lung and head and neck cancers. STRO-006 showed promising preclinical results with potent anti-tumor effects and minimal toxicity. Initial clinical data is expected in the second half of 2027, marking a significant step in Sutro's oncology pipeline development.
Sutro Biopharma's clinical trial news is context for health sector investors. For readers following health stocks, here is Pluang's market snapshot as of Oct 21, 2026 18:42 WIB: Out of 150 priced health-sector US stocks, 65 rose and 76 fell. MESO rose 3.63% to USD 12.86 with a typical hold time of 16 days. NUVB gained 2.94% to USD 4.91 with a 12-day hold. BNGO fell 2.81% to USD 1.21, with Pluang order activity showing 100% sell and a 51-day hold time.
The BBB National Programs’ National Advertising Division reviewed Royal Caribbean Group's advertising related to gratuities and found the company's recent modifications to be supported. Royal Caribbean clarified in its booking process that gratuities...
Deutsche Bank increased its price target for Kroger to $70 from $68, reflecting a potential 10.7% upside. Kroger announced strategic growth initiatives including a $5 billion customer-value investment and plans to open 110 new stores by 2029. The com...
Crown Castle is set to report its Q3 2026 earnings with Wall Street expecting a 5.9% revenue decline to about $1.01 billion, mainly due to drops in site rental and services revenue. However, some forecasts predict a 7.1% rise in earnings per share to...
PypeServer has released Cloud+ version 3.0, enabling HVAC contractors to manage both ductwork and piping fabrication on a single platform. This update allows seamless tracking from design through installation, integrating with existing design softwar...
Kevel secured $52 million in its largest funding round to date, boosting its AI-powered infrastructure for commerce media networks. The capital will accelerate product innovation, transparent AI decisioning, and global expansion, helping retailers an...
